Humana Inc. (NYSE:HUM) Stock Holdings Lifted by Ontario Teachers Pension Plan Board

Ontario Teachers Pension Plan Board lifted its holdings in shares of Humana Inc. (NYSE:HUM) by 6.5% in the third quarter, Holdings Channel.com reports. The institutional investor owned 1,173,535 shares of the insurance provider’s stock after purchasing an additional 71,910 shares during the quarter. Humana makes up 3.2% of Ontario Teachers Pension Plan Board’s portfolio, making the stock its 14th largest holding. Ontario Teachers Pension Plan Board’s holdings in Humana were worth $371,705,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Jennison Associates LLC boosted its stake in Humana by 4.4% in the third quarter. Jennison Associates LLC now owns 333,725 shares of the insurance provider’s stock valued at $105,704,000 after acquiring an additional 13,945 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Humana in the 3rd quarter worth approximately $1,778,000. Banque Cantonale Vaudoise boosted its position in Humana by 8.9% during the 3rd quarter. Banque Cantonale Vaudoise now owns 11,387 shares of the insurance provider’s stock valued at $3,606,000 after purchasing an additional 927 shares during the period. Quest Partners LLC bought a new position in Humana during the 3rd quarter worth $701,000. Finally, S&CO Inc. grew its stake in Humana by 16.4% during the 3rd quarter. S&CO Inc. now owns 33,760 shares of the insurance provider’s stock worth $10,693,000 after buying an additional 4,762 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Price Performance

Shares of NYSE:HUM opened at $278.01 on Wednesday. The company’s fifty day moving average is $278.54 and its two-hundred day moving average is $331.29. The company has a market cap of $33.48 billion, a P/E ratio of 24.62, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $527.18. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts expect that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.27%. The ex-dividend date is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is 31.36%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on HUM shares. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a report on Thursday, October 3rd. Leerink Partners lowered shares of Humana from an “outperform” rating to a “market perform” rating and reduced their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. KeyCorp began coverage on Humana in a report on Friday, October 11th. They set a “sector weight” rating on the stock. UBS Group reduced their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, October 4th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $395.00 target price on shares of Humana in a research report on Tuesday, October 1st. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $315.86.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.